Could Goserelin Used With Chemotherapy Help Preserve Fertility?

According to research published in the British medical journal, goserelin administered with chemotherapy for cancer may help preserve fertility by reducing the risk of ovarian failure and early menopause.
Chemotherapy is one of the most fundamental cancer treatments, providing a significant survival advantage. Depending on breast cancer stage, it is sometimes the main treatment and more often an adjunct (adjuvant) treatment. It is used as the main treatment particularly in advanced cancers spread to distant tissue, and as an adjunct to shrink tumors before surgery or kill possible remaining cancer cells afterward. However, side effects, particularly fertility loss, can sometimes cause breast cancer patients to refuse it. Studies are therefore investigating ways to reduce these effects, and goserelin is among the agents under investigation.
Goserelin is a synthetic form of the hormone GnRH produced in the body. GnRH stimulates the pituitary to release certain hormones, which stimulate estrogen and androgen release from the testes or ovaries. However, externally administered GnRH suppresses the pituitary-testis/ovary pathway, thereby inactivating the testes or ovaries. This suggested that goserelin given with chemotherapy might suppress the ovaries and protect them from chemotherapy damage. A study on this subject was recently published in the British Medical Journal.
The study enrolled premenopausal women with hormone receptor-negative (resistant to hormonal treatment) breast cancer: 218 women were divided into 2 groups. One received standard chemotherapy alone, while the other received chemotherapy with goserelin. Patients were followed for 2 years to assess ovarian failure (infertility). Infertility occurred in %22 of the chemotherapy-only group compared with %8 of the goserelin-plus-chemotherapy group. Pregnancy also occurred in %22 of the goserelin group versus %11 in the other group.
In conclusion, chemotherapy has an indispensable role in breast cancer and many other cancers. However, its side effects can seriously affect quality of life. Fertility loss is a relatively common side effect of chemotherapy regimens. The possibility that goserelin administered with chemotherapy may preserve fertility by reducing ovarian failure and early menopause is therefore very encouraging. However, as the research team notes, some data are missing, and caution is advisable when applying these findings clinically.
Sources
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.